Low Philip S

Avg. Two Year Performance

131% Avg. Purchase Return
52% Compound
22% Avg. Sale Return
10% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return9%(5%)56%119%131%
Purchase Success Rate3 of 42 of 43 of 42 of 43 of 4
Average Sale Return3%(18%)(70%)(10%)22%
Sale Success Rate3 of 42 of 41 of 41 of 42 of 4

Endocyte, Inc.

Drugs » Drug Manufacturers - Major

Chief Science Officer, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Quince Therapeutics, Inc.

Other » Other

Director:

Holdings: 519.28K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--